In collaboration with HOPA, COA, and Oncology State Societies.
The management of non-Hodgkin lymphoma (NHL) is complex, and oncology pharmacists play a critical role in mastering the complex integration and toxicity of novel agents. Join leading experts in hematologic cancers for PTCE's 2026 Lymphoma Day of Education to review the pathophysiology of NHL subtypes, including aggressive diffuse large B-cell lymphoma and relapsing follicular lymphoma, and pharmacology of novel agents in both frontline and relapsed settings. Register early for these expert-led sessions that will examine clinical and operational strategies for the integration of CAR T-cell therapy and bispecific antibodies in NHL treatment.
James Davis, PharmD, BCOP
Clinical Pharmacy Specialist, Malignant Hematology
MUSC Hollings Cancer Center
Charleston, South Carolina
Accreditation Information
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. The following universal activity numbers (UANs) have been approved:
- 0290-0000-26-219-L01-P
- 0290-0000-26-220-L01-P
- 0290-0000-26-221-L01-P
- 0290-0000-26-222-L01-P
Obtaining Credit
All participants who attended the live virtual broadcast need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Instructions on receiving credit will be provided the day of the event.